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ScienceDirectDeamination of the nucleobases in DNA and RNA is a result of
spontaneous hydrolysis, endogenous or environmental factors as
well as deaminase enzymes. Adenosine is deaminated to inosine
which is miscoding and preferentially base pairs with cytosine. In
the case of DNA, this is a premutagenic event that is counteracted
by DNA repair enzymes specifically engaged in recognition and
removal of inosine. However, in RNA, inosine is an essential
modification introduced by specialized enzymes in a highly
regulated manner to generate transcriptome diversity. Defect
editing is seen in various human disease including cancer, viral
infections and neurological and psychiatric disorders. Enzymes
catalyzing the deaminase reaction are well characterized and
recently an unexpected function of Endonuclease V in RNA
processing was revealed. Whereas bacterial Endonuclease V
enzymes are classified as DNA repair enzymes, it appears that the
mammalian enzymes are involved in processing of inosine in
RNA. This yields an interesting yet unexplored, link between DNA
and RNA processing. Further work is needed to gain
understanding of the impact of inosine in DNA and RNA under
normal physiology and disease progression.
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Imbalance in the nucleotide pools are found in several
human diseases, including cancer, immunodeficiency and
neurological disorders. Formation and subsequent incorp-
oration of non-canonical nucleotides in DNA may increase
mutation frequencies representing one important mech-
anism underlying these pathologies. Inosine triphosphate
(ITP) is one of the most common non-canonical nucleo-
tides. Cells hydrolyze ITP to its monophosphate to avoid
incorporation in DNA. In RNA inosine is a normal and
essential modification introduced by specific deaminases.
However, associations are found between aberrant A-to-ICurrent Opinion in Genetics & Development 2014, 26:116–123 RNA editing and human disease, primarily neurological
and psychiatric disorders and cancer. Here, we review the
mechanisms processing inosine in DNA and RNA and the
biological impact of inosine in DNA and RNA under
normal physiology and pathology.
Inosine in DNA
Deamination of DNA refers to the loss of exocyclic amino
groups from the DNA bases and in the case of deoxya-
denosine (dA), deoxyinosine (dI; the corresponding base
is hypoxanthine, Hx) is formed (Figure 1a). This amino-
to-keto conversion alters the hydrogen bonding proper-
ties of the base from a hydrogen bond donor to a hydrogen
bond acceptor. The DNA replication machinery reads dI
as deoxyguanosine (dG) and deoxycytidine (dC) will be
inserted (Figure 1b) resulting in a transition mutation [1].
Deoxyinosine may also pair with the three other DNA
bases (deoxythymidine (dT), dA and dG), but the dI:dC
pair is the most stable [2].
DNA deamination is a relatively common event that
occurs spontaneously in cells and is enhanced by
exposure to nitrosative compounds from the environment
(i.e. tobacco smoke, cured meat and air pollution)
(Figure 2a). The bioregulator nitric oxide (NO) pro-
duced by NO synthases in activated phagocytes during
inflammation and infection can also lead to deamination
[3,4]. Of the DNA bases dC is most frequently deami-
nated (yields deoxyuridine (dU)) and is estimated to
occur about 200 times per mammalian cell per day.
Deamination of dA is a minor reaction that occurs at 2–
3% of the rate of dC deamination [5]. Amino groups
engaged in base pairing will be protected and the dea-
mination rate of double-stranded DNA is only 0.5–0.7%
of that of single-stranded DNA. Another mechanism
contributing to nucleobase deamination, is deaminase
enzymes such as activation-induced cytidine deaminase
(AID) converting dC to dU during immunoglobulin
diversification in B lymphocytes [6]. No known deami-
nase acts on adenine in DNA, however, an adenosine
deaminase (ADA) converts free dA to dI which can be
further metabolized to Hx [7]. Hx can be salvaged to
deoxyinosine monophosphate (dIMP) and subsequently
converted to deoxyinosine triphosphate (dITP) by a
currently poorly understood pathway [8]. dITP may also
be produced by spontaneous deamination of dATP. DNA
polymerases can use dITP as a substrate during DNA
replication and will most often insert dITP opposite a C
(Figure 2a) [9,10]. Normally the intracellular dITP con-
centration is kept low compared to the canonical deox-
ynucleotide triphosphates (dNTPs) [8]. The steady state
level of inosine in DNA is 0.5–1 per 106 nucleotides inwww.sciencedirect.com
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Deamination of adenosine yields inosine. (a) Loss of the exocyclic amino group in adenosine yields inosine. (b) Inosine (I) base pairs with cytosine (C) in
a Watson-Crick bonding configuration. (c) Inosine opposite the original thymine (T) represents a less stable base pair.different mouse tissue, E. coli and S. cerevisiae [11,12,13]
comparable to the level of the more studied oxidation
product of dG, 8-oxo-7,8-dihydro-20-dG.
In addition to its premutagenic properties, dI may lead to
altered recognition sites for DNA binding proteins with
consequences for example gene expression. To avoid
such treats, cells harbor two main pathways for inosine
repair: base excision repair (BER) and Endonuclease V.
Processing of inosine in DNA
BER is the major pathway for repair of damaged DNA
bases and proceeds through multiple steps requiring
several enzymes [14]. The first step is initiated by
DNA glycosylases recognizing and removing damaged
DNA bases such as alkylated, oxidized and deaminated
bases. In most pro- and eukaryotic species the alkyl
adenine DNA glycosylases (Escherichia coli AlkA; Sacchar-
omyces cerevisiae MAG; mammalian Aag), remove Hx from
genomic DNA (Figure 2a) [15,16]. In Schizosaccharomyces
pombe, thymine DNA glycosylase (Thp1) rather than
Mag1 appears to be the inosine-specific DNA glycosylase
[17,18]. An alternative excision repair pathway for the
removal of deaminated purine bases has been proposed,
in which Endonuclease V (EndoV) initiates repair by
cleavage of the second phosphodiester bond 30 to inosine
(Figures 2a and 3a) [19]. Further, a small patch of DNA
containing the lesion is removed by exonucleases or
endonucleases and finally, DNA polymerase and DNAwww.sciencedirect.com ligase completes repair by gap filling and ligation.
Although this alternative excision repair mechanism
has been reconstituted in vitro with recombinant proteins
[20], in vivo data supporting this pathway is lacking.
Endonuclease V
The molecular basis for recognition and cleavage of
inosine-containing DNA by prokaryotic EndoV has been
elucidated through structure determination of EndoV-
DNA complexes [21]. EndoV has an aba fold with a
central 8-stranded b-sheet flanked on either side by a-
helices (Figure 3b) — including a ribonuclease H-like
motif shared with nucleases such as RNaseH [22,23],
RuvC [24] and UvrC [25], as well as Piwi protein
[26,27] and the Piwi subdomain of Argonaute [28,29],
being part of the RNA-induced silencing complex (RIS-
C). The DNA binding surface is positively charged and
includes a base lesion recognition pocket, a DNA strand
separating wedge and an Mg2+ binding catalytic pocket
(Figure 3b–d). The conserved strand-separating wedge is
playing an important role as a sensor by presenting the
deaminated bases to the recognition pocket (Figure 3c).
Similar to DNA glycosylases, EndoV binds to the minor
groove of the DNA, inducing distortions in the DNA
helix, and flips the modified base into a specific recog-
nition pocket. However, while DNA glycosylases remove
the base itself by hydrolytic cleavage of the N-glycosidic
bond, EndoV incises the DNA backbone one base offset
on the 30 side of inosine using a separate catalytic activeCurrent Opinion in Genetics & Development 2014, 26:116–123
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Introduction and processing of inosines in nucleic acids. (a) Inosine in DNA (shown as a red I) is a result of spontaneous hydrolytic or nitrosative stress
induced deamination of adenosine as well as misincorporation of dIMP during DNA replication. The deaminated base is recognised and removed by
certain DNA glycosylases initiating base excision repair or by Endonuclease V initating repair by an alternativ pathway involving yet unknown proteins.
(b) In addition to the three mechanisms described for DNA, a fourth mechanism applies for RNA: deamination by adenosine deaminases (ADAR). In
contrast to the random inosines introduced by the three first mechanisms, the ADAR enzymes introduce inosines at specific sites in certain RNAs. How
(and if) inosine-containing RNAs are processed are poorly understood, but recently Endonuclease V was shown to cleave inosine-containing RNA with
high efficiency. Also the Tudor-SN nuclease has been linked to processing of inosine-RNA.site (Figure 3d). EndoV binds strongly to the incised
product as a result of this dual interface securing both
ends of the incised DNA.
Inosine in RNA
The mechanisms described above leading to deaminated
adenosines in DNA (spontaneous deamination, nitrosa-
tive stress, and misincorporation) also apply for RNA
(Figure 2b). However, a major difference exists: while
inosine in DNA is regarded as damage, inosine in RNA is
a normal and essential modification introduced by specific
deaminases (Figure 2b). The bases of RNA are frequently
co-transcriptionally or post-transcriptionally edited and
the A-to-I conversion is probably the most common [30].
In tRNA, the deamination is catalyzed by adenosine
deaminases acting on tRNA (ADAT) whereas in mRNA
and non-coding RNA, the responsible enzymes are
the related adenosine deaminases acting on RNA
(ADAR) [31] (Figure 4). Inosine in rRNA is not reported.
In tRNA, inosine is found in the wobble 34 position and is
an absolute requirement for protein translation
(Figure 4a). The relaxed base pairing properties of ino-
sine allow a single tRNA to decode multiple codons. In
bacteria, only tRNAArg has inosine, whereas in mammalsCurrent Opinion in Genetics & Development 2014, 26:116–123 eight different tRNAs have inosine at the wobble position
[32]. A-to-I editing of mRNA may result in recoding of
the genetic information or generation/deletion of splice
sites and stop codons, both contributing to protein diver-
sity (Figure 4b). In fact, it is believed that A-to-I editing
has been fundamental for human development and cog-
nitive complexity. Actually, most ADAR substrates are
transcripts for neuronal transporters and channel proteins
in the brain and the editing is critical for normal brain
development and function [33]. Also, ADAR enzymes are
mostly found in higher eukaryotes [34]. Despite the
initial expectations, only a limited number of genes
(60) are subjected to site selective A-to-I editing within
their coding sequences. It appears that the vast majority
of editing (90%) occurs in non-coding regions that
contain repetitive elements such as Alus and LINEs,
and in 50 and 30 untranslated regions (UTRs) [35,36].
High-throughput RNA sequencing have enabled tran-
scriptome-wide identification of A-to-I edited sites and
interestingly, about 15 000 edited sites is mapped in
about 2000 different genes [37]. In many regions multiple
adenosines are deaminated, a phenomenon referred to as
hyperediting. The biological significance of repetitive
RNA editing is largely unknown, but examples havewww.sciencedirect.com
Adenine deamination Alseth, Dalhus and Bjøra˚s 119
Figure 3
(a)
(b) (c) (d)
I
H/OH
C-term Active site
N-term
Wedge
H/OHO O
OH
5′
3′
3′
5′
5′
3′
Mg2+
Tyr80 Inosine
PO4– PO4–PO4–
Any base
Current Opinion in Genetics & Development
Structural details of Endonuclease V. (a) Endonuclease V cleaves the second phosphodiester bond 30 to inosine by hydrolysis and leaves 30-OH and 50-
P termini. The inosine residue is not removed. (b) Tma EndoV is a mixed ab-fold protein with a central b-strand flanked by a-helices. (c,d) EndoV binds
to the minor groove of DNA, which is severely bent (double-headed arrows indicate direction of the DNA helix axes). (c and d) The conserved wedge
motif (orange) splits the DNA, and the deaminated base (red) is flipped into a nucleotide binding pocket behind the wedge. The nearby active site
(yellow) contains a Mg2+ ion (green sphere) involved in phosphodiester hydrolysis (a). Both the 30 and 50 ends of the incised product bind to the protein
through several hydrogen bonds and ionic interactions (dashed lines). Wedge residue Tyr80 is stacking with the base on the 30 side of the nick.shown involvement in RNA induced gene silencing
(RNAi) and microRNA (miRNA) modulation, stabiliz-
ation of mRNA and nuclear retention (Figure 4) [38].
Viral RNA is also often deaminated by host ADARs which
has pro- or antiviral effects depending on the specific type
of virus (Figure 4) [39].
Processing of inosine in RNA
Since the identification of ADAR and ADAT enzymes in
the early 90s, the presence and importance of inosine in
RNA have been well recognised [31]. A-to-I editing of
RNA substrates are rarely complete and it appears that
ADAR activity is dynamically regulated through yet
poorly understood mechanisms [34]. In addition to tight
regulation of ADAR activity, specific destruction of A-to-I
edited transcripts could be a way to control the level of
editing. Until very recently, no such activity was proven.
Last year, Morita et al. [40] and Vik et al. [41] both
demonstrated efficient cleavage of inosine-containing
RNA by human EndoV suggesting that EndoV could
fulfill such a role (Figure 2b). The cytosolic localization
of hEndoV supports this notion [42]. Another protein, the
Tudor staphylococcal nuclease 1 (Tudor-SN) has alsowww.sciencedirect.com been linked to processing of inosine-containing RNA
[43,44] (Figure 2b). Tudor-SN was initially identified
in extracts from Xenopus laevis by its ability to bind
inosine-containing RNA [43]. Tudor-SN has five staphy-
lococcal nuclease-like domains (SN1–5) in addition to
one tudor domain and is a multifunctional protein parti-
cipating in diverse processes including RNAi, transcrip-
tional coactivation and mRNA splicing [45]. The specific
activity for Tudor-SN for inosine-containing RNA has not
been thoroughly addressed and the individual contri-
bution of EndoV and Tudor-SN remains to be elucidated.
Inosine and association with pathology and
disease
The concentrations of cellular nucleotides are highly
controlled [46,47]. Defects in genes involved in the
nucleotide metabolism and imbalance in the nucleotide
pools are found in several human diseases such as immu-
nodeficiency, hyperuricemia with neurological symptoms
(Lech-Nyman syndrome) and several types of cancer
[48,49]. One possible mechanism underlying these path-
ologies involves the formation of non-canonical NTPs
with subsequent incorporation into DNA and RNACurrent Opinion in Genetics & Development 2014, 26:116–123
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A-to-I editing of RNA and its consequences. (a) Adenosine at the wobble position (A34) of certain tRNAs undergoes A-to-I editing catalyzed by ADAT.
This modification enlarges the codon recognition capacity during protein synthesis. ADAT orthologs are essensial in S. cerevisiae and E. coli,
underscoring the critical function of inosine at the wobble position. (b) ADARs are double-stranded specific enzymes catalyzing the deamination of
adenosine to inosine in RNA. Inosine is interpreted as G by cellular enzymes and A-to-I editing may result in amino acid changes, creation or deletion of
splice sites and stop codons as well as modification of mRNA stability and nuclear export. Small interfering RNA (siRNA) are also subjected to A-to-I
editing resulting in antagonistic effects on RNAi probably by inhibiting Dicer activity or by increased degradation by the Tudor-SN nuclease. For pri-/
pre- miRNA, A-to-I editing inhibits processing by Drosha and Dicer and suppresses miRNA function. Further, editing in the specificity region, the seed
sequence of miRNA alters target gene selection increasing miRNA diversity. Viral RNA may be edited by host ADAR which have either pro- of antiviral
effects depending on the particular type of virus.contributing to mutagenesis and carcinogenesis. Cells
express enzymes counteracting such threats, for example
inosine triphosphate pyrophosphatase (ITPA in mamma-
lian cells, RdgB in E. coli) that hydrolyses dITP to its
monophosphate form. Mutations in the ITPA orthologs in
model organisms lead to genetic instability and, in mice,
to severe developmental abnormalities [50]. It has been
shown that Itpa/mice accumulates inosine in DNA and
RNA [51,52]. In contrast, ITPA deficiency in human is
seemingly innocuous, but has been linked to psychologi-
cal disorders [53] and overexpression of ITPA is seen in
several cancers [54]. The lack of a severe phenotype in
humans may be due to expression of redundant activities
such as the IDP hydrolase NUDT16 [51]. Notably, the
rdgB recA double mutant in E. coli is lethal, while the triple
mutant nfi (EndoV) rdgB recA is viable [55]. Thus it
appears that excessive incorporation of inosine in DNA
and subsequent cleavage by EndoV is cytotoxic to cells in
absence of recombination repair. Studies in mice show
that Aag is an important suppressor of colon cancer in
response to chronic inflammation and Helicobacter pylori
infection [56]. Despite the condition of inflammation in
this model, the level of inosine in the DNA did not
increase, rather etheno-adducts eA and eC accumulatedCurrent Opinion in Genetics & Development 2014, 26:116–123 in the Aag/ mice probably contributing to carcinogen-
esis [56]. For humans there is (yet) no known link
between defect inosine repair and pathology.
For RNA however, clear associations are found between
aberrant A-to-I RNA editing and human disease, prim-
arily neurological and psychiatric disorders and cancer
[34,57]. In amyotrophic lateral sclerosis, downregulation
of ADAR2 activity results in hypoediting of the pre-
mRNA of the glutamate receptor GluR-B leading to
death of motor neurons [58]. Underediting of the sero-
tonin receptor 5-HT2cR pre-mRNA has been associated
to depression and schizophrenia [59]. Reduced editing of
GluR-B mRNA has also been reported in human gliomas
[60]. Recently, a study by Chan et al. showed dysregula-
tion of ADAR1 and ADAR2 in human hepatocellular
carcinoma resulting in ‘RNA editome’ imbalance [61].
Not only were protein coding exons found hypoedited or
hyperedited, but also noncoding transcripts (Alu
elements and miRNA) [62]. Underediting of Alu contain-
ing transcripts have been identified in several other
tumours originating from brain, prostate, lung, kidney
and testis among others [63]. Editing is unlikely an early
initiation hit along the transformation slope, rather it iswww.sciencedirect.com
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appears that in cancer, editing imbalance is complex
being either tumour-suppressive or oncogenic depending
on the actual target genes [62].
Perspectives
The current literature reveals that disruption of critical
nodes in the purine metabolism network causes large
increases of hypoxanthine in DNA and RNA. These
results have implications for the pathophysiological
mechanisms underlying many human metabolic disorders
and suggest that disturbances in purine metabolism
caused by genetic polymorphisms could increase the
burden of mutagenic deaminated nucleobases in DNA
and interfere with gene expression and RNA function, a
situation possibly exacerbated by the nitrosative stress of
concurrent inflammation. However the biological impact
of inosine in DNA and RNA under normal physiology and
pathology is still poorly understood. Further investi-
gations taking advantage of cellular model systems, trans-
genic animal models, high resolution methods for
detection of inosine and proteomics approaches are
required to unravel biochemical mechanisms and regu-
latory networks governing inosine metabolism in RNA
and DNA.
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